IFNG and Alzheimer disease: Administrating anti-IFN-γ antibody and immuno-modulative TGF-β in AD mouse models could effectively alleviate the Th1 cell-mediated neuroinflammation and cognitive decline (Browne et al., 2013; Chen et al., 2015).